Cargando…

Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors

Off-label use of medications is still a common practice in pediatric rheumatology. JAK inhibitors are authorized in adults in the treatment of rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Although their use is not authorized yet in children, JAK inhibitors, based on their mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pin, Alessia, Tesser, Alessandra, Pastore, Serena, Moressa, Valentina, Valencic, Erica, Arbo, Anna, Maestro, Alessandra, Tommasini, Alberto, Taddio, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590237/ https://www.ncbi.nlm.nih.gov/pubmed/33092242 http://dx.doi.org/10.3390/ijms21207767

Ejemplares similares

Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation
por: Girardelli, Martina, et al.
Publicado: (2021)

Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies
por: Rispoli, Francesco, et al.
Publicado: (2021)

An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers
por: Pin, Alessia, et al.
Publicado: (2019)

Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
por: Della Paolera, Sara, et al.
Publicado: (2021)

Clinical significance of hyper-IGA in a pediatric laboratory series
por: Pastore, Serena Ifmach, et al.
Publicado: (2014)

A toddler with an unusually severe polyarticular arthritis and a lung involvement: a case report
por: Basile, Pietro, et al.
Publicado: (2022)

Inborn Errors of Immunity in Children with Autoimmune and Allergic Complaints: A Single Center Experience from Diagnosis to Treatment
por: Boz, Valentina, et al.
Publicado: (2023)

Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain
por: Tesser, Alessandra, et al.
Publicado: (2021)

5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2014)

Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus
por: Tesser, Alessandra, et al.
Publicado: (2020)

Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I Interferons
por: Tesser, Alessandra, et al.
Publicado: (2021)

Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature
por: Trombetta, A., et al.
Publicado: (2019)

Chronic recurrent multifocal osteomyelitis: experience from a single pediatric rheumatology center over the past ten years
por: Pastore, Serena, et al.
Publicado: (2014)

PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
por: Vatta, P, et al.
Publicado: (2013)

Chronic limping in childhood, what else other than juvenile idiopathic arthritis: a case series
por: Tumminelli, Cristina, et al.
Publicado: (2023)

Ultrasonographic Assessment for Tenosynovitis in Juvenile Idiopathic Arthritis with Ankle Involvement: Diagnostic and Therapeutic Significance
por: Della Paolera, Sara, et al.
Publicado: (2022)

Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children’s Hospital
por: Giurin, Maria Sole, et al.
Publicado: (2022)

Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency
por: Boz, Valentina, et al.
Publicado: (2021)

Neither hereditary periodic fever nor periodic fever, aphthae, pharingitis, adenitis: Undifferentiated periodic fever in a tertiary pediatric center
por: De Pauli, Silvia, et al.
Publicado: (2018)

PReS-FINAL-2338: Fate of lymphocytes after withdrawal of Tofacitinib treatment
por: Tommasini, A, et al.
Publicado: (2013)

In Vitro Effects of Sulforaphane on Interferon-Driven Inflammation and Exploratory Evaluation in Two Healthy Volunteers
por: Genova, Elena, et al.
Publicado: (2021)

Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report
por: Burlo, Francesca, et al.
Publicado: (2023)

Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies
por: Valencic, Erica, et al.
Publicado: (2021)

Off-label drugs use in pediatric palliative care
por: De Zen, Lucia, et al.
Publicado: (2018)

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
por: Haulrig, Morten B, et al.
Publicado: (2021)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

The off-label use of anakinra in pediatric systemic autoinflammatory diseases
por: Maniscalco, Valerio, et al.
Publicado: (2020)

Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations
por: Belayneh, Anteneh, et al.
Publicado: (2020)

Off-label use of canakinumab in pediatric rheumatology and rare diseases
por: Del Giudice, Emanuela, et al.
Publicado: (2022)

Biologics in Dermatology: Off-Label Indications
por: Mitra, Debdeep, et al.
Publicado: (2020)

Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach
por: Taddio, Andrea, et al.
Publicado: (2017)

PReS-FINAL-2101: Nitrous oxide analgesia for intra-articular injection in juvenile idiopathic arthritis: our experience
por: Pastore, S, et al.
Publicado: (2013)

Guideline for the management of pediatric off-label use of drugs in China (2021)
por: Meng, Min, et al.
Publicado: (2022)

Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy
por: van der Zanden, Tjitske M., et al.
Publicado: (2022)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

Off label use of lithium in the treatment of Huntington's disease: A case series
por: Danivas, Vijay, et al.
Publicado: (2013)

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
por: Capecchi, Marco, et al.
Publicado: (2021)

Off-label use of biological agents in the management of uveitis: experience from a pediatric rheumatology centre
por: Campanilho-Marques, Raquel, et al.
Publicado: (2011)

Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease
por: Loganes, Claudia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1vrclp4a2fe3es4jib7un1gt04